December 2, 2020

Modulim's Clarifi Imaging System Receives CE Mark for Microvascular Assessment

December 2, 2020—Modulim announced that it has received CE Mark certification for the Clarifi imaging system, allowing the company to expand marketing and distribution throughout Europe and apply for registration in other international markets that recognize the CE Mark.

According to the company, the Clarifi system is powered by Modulim's Spatial Frequency Domain Imaging (SFDI) technology, an optical imaging technology that assesses tissue and microvascular function by quantitatively mapping tissue oxygenation and perfusion at the point of care. The platform is designed to assess potential circulatory compromise to manage and treat diabetic, venous, and pressure ulcers, acute and chronic wounds, burns, and amputations.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

December 2, 2020

Modulim's Clarifi Imaging System Receives CE Mark for Microvascular Assessment

Current Issue

Keep In Touch